Skip to content

Depression research published in 2017

Page 3 of 7: studies 41 to 60 of 128, newest first. Back to the depression overview

Studies

Mindfulness-Based Interventions for Anxiety and Depression

Psychiatric Clinics of North America September 18, 2017 Stefan G Hofmann, Angelina F Gómez

Synopsis This article reviews the ways in which cognitive and behavioral treatments for depression and anxiety have been advanced by the application of mindfulness practices. Research on mindfulness-based interventions (MBIs) has increased exponentially in the past decade. The most common include Mindfulness-Based Stress Reduction (MBSR) and Mindfulness-Based Cognitive Therapy (MBCT). MBIs have...

Serotonin and brain function: a tale of two receptors.

Journal of Psychopharmacology August 31, 2017 R L Carhart-Harris, D J Nutt

Previous attempts to identify a unified theory of brain serotonin function have largely failed to achieve consensus. In this present synthesis, we integrate previous perspectives with new and older data to create a novel bipartite model centred on the view that serotonin neurotransmission enhances two distinct adaptive responses to adversity, mediated in large part by its two most prevalent and...

Mindfulness-based Intervention in Elementary School Students With Anxiety and Depression: A Series of n-of-1 Trials on Effects and Feasibility.

Journal of Evidence-Based Complementary & Alternative Medicine August 30, 2017 Catherine Malboeuf-Hurtubise, Éric Lacourse, Catherine Herba et al.

Mindfulness-based interventions constitute a promising option to address anxiety and depression in elementary school students. This study evaluated the effect of a mindfulness-based intervention on anxiety and depression in elementary school students with a diagnosis of anxiety or depression disorder. A single-subject experimental A-B-A design was used. Participants were three elementary school...

Backing into the future: pharmacological approaches to the management of resistant depression

Psychological Medicine August 25, 2017 Philip J. Cowen 38 citations

Pragmatic studies indicate that a substantial number of depressed patients do not remit with current first-line antidepressant treatments and after two failed treatment steps the chance of remission with subsequent therapies is around 15%. This paper focuses on current evidence for pharmacological treatments in resistant depression as well as possible future developments. For patients who have...

Mindfulness mediates the physiological markers of stress: Systematic review and meta-analysis.

Journal of Psychiatric Research August 23, 2017 Michaela C. Pascoe, David R Thompson, Zoe M Jenkins et al.

Meditation is a popular form of stress management, argued to mediate stress reactivity. However, many studies in this field commonly fail to include an active control group. Given the frequency with which people are selecting meditation as a form of self-management, it is important to validate if the practice is effective in mediating stress-reactivity using well-controlled studies. Thus, we...

Synaptic Regulation of a Thalamocortical Circuit Controls Depression-Related Behavior.

Cell Reports August 22, 2017 Oliver H Miller, Andreas Bruns, Imen Ben Ammar et al.

The NMDA receptor (NMDAR) antagonist ketamine elicits a long-lasting antidepressant response in patients with treatment-resistant depression. Understanding how antagonism of NMDARs alters synapse and circuit function is pivotal to developing circuit-based therapies for depression. Using virally induced gene deletion, ex vivo optogenetic-assisted circuit analysis, and in vivo chemogenetics and...

Anhedonia as a clinical correlate of suicidal thoughts in clinical ketamine trials.

Journal of Affective Disorders August 15, 2017 Elizabeth D. Ballard, Kathleen E. Wills, Níall Lally et al.

Identifying clinical correlates associated with reduced suicidal ideation may highlight new avenues for the treatment of suicidal thoughts. Anhedonia occurs across psychiatric diagnoses and has been associated with specific neural circuits in response to rapid-acting treatments, such as ketamine. This analysis sought to evaluate whether reductions in suicidal ideation after ketamine...

Dextromethorphan/quinidine pharmacotherapy in patients with treatment resistant depression: A proof of concept clinical trial.

Journal of Affective Disorders August 15, 2017 James W. Murrough, Elizabeth Wade, Sehrish Sayed et al.

At least one-third of patients with major depressive disorder (MDD) have treatment-resistant depression (TRD), defined as lack of response to two or more adequate antidepressant trials. For these patients, novel antidepressant treatments are urgently needed. The current study is a phase IIa open label clinical trial examining the efficacy and tolerability of a combination of dextromethorphan...

A Physician’s Attempt to Self-Medicate Bipolar Depression with N,N-Dimethyltryptamine (DMT)

Journal of Psychoactive Drugs August 8, 2017 Tanida Brown, Wanda Shao, Shehzad Ayub et al. 21 citations

N,N-dimethyltryptamine (DMT) is a psychoactive substance that has been gaining popularity in therapeutic and recreational use. This is a case of a physician who chronically took DMT augmented with phenelzine in an attempt to self-medicate refractory bipolar depression. His presentation of altered mental status, mania, and psychosis is examined in regards to his DMT use. This case discusses DMT,...

A closer look at the relationship between the default network, mind wandering, negative mood, and depression.

Cognitive, Affective, & Behavioral Neuroscience August 2017 Shaghayegh Konjedi, Reza Maleeh

By a systematic analysis of the current literature on the neural correlates of mind wandering, that is, the default network (DN), and by shedding light on some determinative factors and conditions which affect the relationship between mind wandering and negative mood, we show that (1) mind wandering per se does not necessarily have a positive correlation with negative mood and, on the higher...

[Clinical and biological predictors of ketamine response in treatment-resistant major depression: Review].

L'Encephale August 2017 B Romeo, W Choucha, P Fossati et al.

The aim of this review was to determine the clinical and biological predictors of the ketamine response. A systematic research on PubMed and PsycINFO database was performed without limits on year of publication. The main predictive factors of ketamine response, which were found in different studies, were (i) a family history of alcohol dependence, (ii) unipolar depressive disorder, and (iii)...

DOI: 10.1016/j.encep.2016.06.005 (opens in new tab) Full text (opens in new tab) Ketamine Kétamine Major depressive episode Predictors response +1

Exploring a post-traumatic stress disorder paradigm in Flinders sensitive line rats to model treatment-resistant depression II: response to antidepressant augmentation strategies.

Acta Neuropsychiatrica August 2017 Sarel Jacobus Brand, Brian Herbert Harvey

Post-traumatic stress disorder (PTSD) displays high co-morbidity with major depression and treatment-resistant depression (TRD). Earlier work demonstrated exaggerated depressive-like symptoms in a gene×environment model of TRD and an abrogated response to imipramine. We extended the investigation by studying the behavioural and monoaminergic response to multiple antidepressants, viz....

DOI: 10.1017/neu.2016.50 (opens in new tab) Full text (opens in new tab) Nmda antagonist Animal model Noradrenaline reuptake inhibitor Serotonin reuptake inhibitor +1

Oral Ketamine in Treatment-Resistant Depression: A Clinical Effectiveness Case Series.

Journal of Clinical Psychopharmacology August 2017 Maryam I Al Shirawi, Sidney H. Kennedy, Keith T. Ho et al.

The aim of the study was to assess the effectiveness, tolerability, and safety of oral ketamine as an antidepressant treatment in adults with treatment-resistant depression. We reviewed retrospective data on 22 patients with treatment-resistant depression, who failed at least 3 adequate antidepressant treatment trials and 1 adequate trial of repetitive transcranial magnetic stimulation;...

The effectiveness of mindfulness training on reducing the symptoms of postpartum depression

Electronic Physician July 25, 2017 Hajieh Sheydaei, Azizreza Ghasemzadeh, Amir Lashkari et al. 22 citations

BACKGROUND AND AIM: Postpartum depression is one of the prevalent disorders among new mothers. The present research aimed to examine the effectiveness of mindfulness training on reducing the symptoms of postpartum depression. METHOD: The present quasi-experimental research was conducted on 410 new mothers in Shahid Chamran Hospital, Tehran in 2014. Using the Beck Depression Inventory (BDI),...

Ketamine for Depression, 4: In What Dose, at What Rate, by What Route, for How Long, and at What Frequency?

The Journal of Clinical Psychiatry July 20, 2017 Chittaranjan Andrade 179 citations

BACKGROUND: Ketamine, administered in subanesthetic doses, is an effective off-label treatment for severe and even treatment-refractory depression; however, despite dozens of studies across nearly 2 decades of research, there is no definitive guidance on matters related to core practice issues. METHODS: This article presents a qualitative review and summary about what is known about ketamine...

Role of Mindfulness and Psychological Wellbeing Between External Locus of Control and Depression: A Moderated Mediation Model

Peshawar Journal of Psychology and Behavioral Sciences July 12, 2017 Sadia Niazi, Adnan Adil

The present research aimed at examining the role of mindfulness and psychological wellbeing in the relationship between external locus of control and depression. Five Facet Mindfulness Questionnaire (Baer, 2003), Ryff Scale of Wellbeing (Ryff, 1989), DAAS Depression Subscale (Lovibond & Lovibond, 1995), and Rotter’s Locus of Control Scale (Rotter, 1966) were administered on a convenient sample...

Combining emotion regulation and mindfulness skills for preventing depression relapse: a randomized-controlled study

Borderline Personality Disorder and Emotion Dysregulation July 5, 2017 Matilde Elices, Joaquim Soler, Albert Feliu-Soler et al.

BackgroundDialectical behavioral therapy (DBT) skills have become increasingly used to treat several psychiatric conditions, including major depressive disorder (MDD). The aim of the study was to investigate the efficacy of an intervention that combines emotion regulation and mindfulness skills of DBT to prevent depression relapse/recurrence.MethodsA total of 75 individuals (79% females; mean...

Burnout and Mindfulness Self-Compassion in Nurses of Intensive Care Units: Cross-Sectional Study.

Holistic Nursing Practice July 1, 2017 Pilar Gracia-Gracia, Bárbara Oliván-Blázquez

Nursing staff has been identified as one of the main risk groups for the development of burnout. The objective of this study is to analyze the ability of self-compassion mindfulness related to burnout in nurses of intensive care units. The results show that the level of burnout of nursing staff is inversely related to their level of self-compassion.